WEN:NASDAQWendy's Company (The) Analysis
Data as of 2026-08-30 - not real-time
$8.27
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
At $8.27, The Wendy's Company shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has gained 6.6%. With RSI at 50.5 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $7.06 up to resistance at $9.14.
On valuation the read is fair — an earnings multiple of 11.8, absent a reliable peer benchmark. Consensus targets land 5.8% below where the shares trade now. The 3.58% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 79.0%, a beta of 0.33 and a maximum drawdown of 41.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 4/10 conviction on the long call.
On valuation the read is fair — an earnings multiple of 11.8, absent a reliable peer benchmark. Consensus targets land 5.8% below where the shares trade now. The 3.58% dividend yield looks covered by current payout levels.
The composite risk read is 7/10, putting it in elevated territory. With 30-day volatility of 79.0%, a beta of 0.33 and a maximum drawdown of 41.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 4/10 conviction on the long call.
Top Market Events
David Moadel Updated Thu, August 27, 2026 at 2:28 PM UTC 0 Nheyob / Wikimedia Commons Quick Read - WEN sinks 13% after...Wrapping up Q2 earnings, we look at the numbers and key takeaways for the traditional fast food stocks, including...Wendy's faces significant headwinds with US traffic down 12.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 7.70
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 7.70
- Analyst targets imply -5.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Analyst targets imply -5.8% versus the current price
- P/E ratio of 11.8
- Return on equity of 108.0%
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin5.72%
P/E Ratio11.8
ROE108.04%
ROA3.82%
Debt/Equity3380.61
Op. Cash Flow$358.5M
Free Cash Flow$173.3M
Technical Analysis
TrendBullish
RSI50.5
Support$7.06
Resistance$9.14
MA 20$8.30
MA 50$7.86
MA 200$7.70
MACDBearish
VolumeDecreasing
Fear & Greed Index95.66
Valuation
Target Price$7.79
Upside/Downside-5.81%
GradeFair
TypeValue
Dividend Yield3.58%
Risk Assessment
Beta0.33
Volatility79.02%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.